Table 2

Description of diabetes cohorts
Cohort 1a (n=29,058) Cohort 2 (n=41,925)
20-44 (n=3,901) 45-64 (n=10,659) 65-74 (n=7,757) 75+ (n=6,741) All 20-44 (n=3,901) 45-64 (n=10,659) 65-74 (n=7,757) 75+ (n=6,741) All
Demographicsb
Age, mean (SD) 36.2 (6.3) 55.5 (5.6) 69.5 (2.8) 80.6 (4.6) 62.5 (15.0) 36.8 (5.8) 55.3 (5.6) 69.6 (2.9) 81.0 (4.8) 62.4 (15.0)
Female 52.1 44.1 46.0 53.5 47.9 52.3 43.9 44.9 54.5 47.8
Urban 58.3 53.0 48.7 46.3 51.0 55.6 53.4 51.1 47.8 51.8
  Missing <0.1 0.2 0.1 <0.1 0.1 0.1 0.2 0.1 <0.1 0.1
Income Quintile
  Q1 (lowest) 32.7 26.1 25.8 27.1 27.1 32.5 25.7 24.4 25.0 26.1
  Q2 22.0 23.2 23.2 24.7 23.4 23.2 22.1 23.4 23.8 23.0
  Q3 15.4 16.2 17.1 19.1 17.0 14.4 16.4 17.5 19.1 17.0
  Q4 13.5 14.8 15.1 12.8 14.2 13.0 15.1 15.4 14.6 14.8
  Q5 (highest) 15.4 18.2 17.4 15.1 16.9 16.0 19.5 18.0 16.4 17.9
  Missing 0.9 1.5 1.5 1.1 1.3 1.0 1.3 1.4 1.2 1.2
Recent diagnosis 27.5 24.3 21.7 21.3 23.4 16.0 12.6 9.6 8.3 11.3
Outcomes (%)c
AMI 0.5 1.6 2.9 3.3 2.2 0.4 0.9 1.9 3.0 1.6
Stroke 0.3 1.0 2.7 3.7 2.0 0.2 0.7 1.8 2.9 1.4
LEA 0.3 0.8 1.2 1.3 1.0 0.3 0.9 0.9 0.6 0.8
ESRD 0.7 0.5 0.4 0.2 0.4 0.3 0.5 0.5 0.3 0.4
Mortality 0.9 4.0 10.0 22.0 9.4 1.2 3.0 8.4 21.5 8.4
Hosp., any 34.3 43.7 57.6 64.7 51.0 31.7 40.9 55.2 61.8 48.1
Hosp., diabetes 18.6 21.3 26.6 30.2 24.4 14.5 16.8 22.0 24.0 19.5
Comorbidity summary measures, mean (SD)
# diagnoses 6.0 (4.8) 6.2 (4.8) 6.7 (4.7) 7.4 (4.8) 6.6 (4.8) 6.2 (5.7) 6.8 (6.0) 7.9 (6.6) 8.9 (6.8) 7.5 (6.4)
Charlson score 0.4 (0.8) 0.6 (1.2) 0.9 (1.5) 1.2 (1.7) 0.8 (1.4) 0.4 (0.8) 0.6 (1.2) 1.0 (1.7) 1.3 (1.9) 0.8 (1.5)
# drugs 3.1 (3.2) 4.2 (3.5) 5.3 (3.6) 5.9 (3.8) 4.7 (3.7) 3.1 (3.3) 4.5 (3.7) 5.9 (3.8) 6.4 (4.0) 5.1 (3.9)
CDS 2.5 (3.1) 3.9 (3.5) 5.0 (3.6) 5.3 (3.6) 4.3 (3.6) 2.8 (3.4) 4.4 (3.8) 5.6 (3.7) 5.7 (3.7) 4.8 (3.8)

aCohort 1 was defined using administrative data from fiscal years 1996/97 to 1997/98 and Cohort 2 was defined using data from 1996/97 to 2001/02; bNumbers reported are percentages unless otherwise indicated; cOutcomes were defined over a two-year observation period, SD Standard Deviation, Hosp Hospitalization, AMI Acute Myocardial Infarction; LEA Lower Extremity Amputation; ESRD End-Stage Renal Disease, CDS Chronic Disease Score.

Lix et al.

Lix et al. BMC Health Services Research 2013 13:340   doi:10.1186/1472-6963-13-340

Open Data